Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-063-2013

Drug recall · December 5, 2012

Reumofan Plus Tablets recall

Why: Marketed without an approved NDA/ANDA: Samantha Lynn Inc. is recalling Reumofan Plus Tablets because it contains undeclared drug ingredients making it an unapproved drug.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Reumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish)

Lots / codes

all lots within expiry through 2016

Quantity
25,888 Boxes
Company
Samantha Lynn, Inc, Norwalk, CA
Distribution
Nationwide and Canada, Australia, Germany, Brazil, Austria, United Kingdom, India, Chile, Switzerland, Thailand, Japan
Initiated
August 27, 2012 · Voluntary: Firm initiated
Classified
November 23, 2012
Reported
December 5, 2012
Ended
March 18, 2013
How notified
Press Release

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.